Traversing Novel Allogeneic Cellular Therapy Strategies in Hematologic Oncology

Everett Meyer, MD, PhD, discusses the ongoing investigation of Orca-T with reduced-intensity conditioning in hematologic malignancies.

Everett Meyer, MD, PhD, outlines ongoing research and the potential role for Orca-T in advanced hematologic malignancies.

Sagar S. Patel, MD, discusses data from a retrospective analysis of Orca-T and PTCy for hematologic malignancies and its implications for the field.

Sagar S. Patel, MD, discusses efficacy data for Orca-T with reduced intensity conditioning for hematologic malignancies from a retrospective analysis.